RxDoctor Payments Data

Tatyana Marx

Neurology · Morristown, NJNPI 1164686960

Payments from drug & device makers

$9,747in general payments, 2019–2025

Across 630 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$928
  • Biogen$902
  • Pfizer$569
  • Lilly USA, LLC$507
  • Lundbeck LLC$375
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$9,67699%
  • Education$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)94$1,116
Novartis60$928
Biogen56$902
Pfizer39$569
Lilly USA, LLC31$507
Lundbeck LLC24$375
CSL Behring21$361
AstraZeneca(2 entities)19$329
Bristol Myers Squibb18$293
Argenx US, Inc.19$278
Neurocrine Biosciences, Inc.18$275
EMD Serono, Inc.16$233
Boston Scientific5$203
Amgen(2 entities)13$194
Teva Pharmaceuticals USA, Inc.13$188
GE HealthCare11$178
Biohaven Pharmaceutical Holding Company Ltd.14$175
UCB, Inc.11$174
SK Life Science, Inc.9$169
Biohaven Pharmaceuticals, Inc.13$163
Supernus Pharmaceuticals, Inc.12$160
MDD US Operations, LLC10$150
Otsuka America Pharmaceutical, Inc.9$146
Amneal Pharmaceuticals LLC8$120
Avanir Pharmaceuticals, Inc.8$117
Takeda Pharmaceuticals U.S.A., Inc.6$111
Pharmacosmos Therapeutics Inc.1$109
La Jolla Pharmaceutical Company1$97
Avion Pharmaceuticals4$72
Neurelis, Inc.4$70
Medtronic(2 entities)4$59
W. L. Gore & Associates, Inc.3$53
Vanda Pharmaceuticals Inc.4$51
Scilex Pharmaceuticals Inc.3$49
Grifols USA, LLC3$47
Acadia Pharmaceuticals Inc3$46
Genentech USA, Inc.3$43
Almatica Pharma LLC3$42
Abbott2$39
Upsher-smith Laboratories LLC3$38
Sunovion Pharmaceuticals Inc.2$33
Alnylam Pharmaceuticals Inc.2$33
Eisai Inc.2$32
Octapharma USA, Inc.2$31
Impel Pharmaceuticals Inc.2$30
Johnson & Johnson2$29
Currax Pharmaceuticals LLC2$27
Aprecia Pharmaceuticals, LLC2$27
Acorda Therapeutics, Inc2$26
Catalyst Pharmaceuticals, Inc.1$25
Axsome Therapeutics, Inc.1$24
Otter Pharmaceuticals, LLC1$23
Sanofi1$22
Bio Products Laboratory USA, Inc.1$21
GRT US Holding, Inc.1$17
Bausch Health US, LLC1$16
Mallinckrodt Hospital Products Inc.1$16
Mallinckrodt Enterprises LLC1$15
Adamas Pharmaceuticals, Inc.1$14
Merz Pharmaceuticals, LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,747 in reported general payments places this provider in the 65th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,261,111
Medicare patients
1,181
Services billed
12,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5045$756,875
GammakedImmune Globul G/Gly/Iga Avg 4626$491,716
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5013$428,419
IngrezzaValbenazine Tosylate12$103,504
VumerityDiroximel Fumarate11$91,510
Plegridy PenPeginterferon Beta-1a11$87,615
QuliptaAtogepant36$38,176
RytaryCarbidopa/Levodopa21$24,167
VimpatLacosamide28$22,611
Nurtec OdtRimegepant Sulfate13$15,114
Entacapone28$11,635
NuedextaDextromethorphan Hbr/Quinidine12$9,847
Levetiracetam132$7,400
Carbidopa-LevodopaCarbidopa/Levodopa196$6,688
Donepezil Hcl264$6,263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bio Products Laboratory USA, Inc.Gammaplex$21$756,87545 claims
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$111$428,41913 claims
Neurocrine Biosciences, Inc.Ingrezza$275$103,50412 claims
BiogenVumerity$902$91,51011 claims
AbbVieQulipta$1,116$38,17636 claims
Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide$120$27,61132 claims
UCB, Inc.Vimpat$174$22,61128 claims
PfizerNurtec Odt, Dilantin$569$16,38027 claims
Avanir Pharmaceuticals, Inc.Nuedexta$117$9,84712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 521 neurology providers in New Jersey.

Other neurology in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →